← FDA Drug Approvals (Drugs@FDA)

NEVIRAPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2014-04-03

Drug application

FDA Application #

ANDA203411

Application type

Abbreviated New Drug Application (Generic)

Brand name

NEVIRAPINE

Generic name

Nevirapine

Active ingredients

NEVIRAPINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

SANDOZ

First approval

2014-04-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown